LN
Therapeutic Areas
IDP Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| IDP-121 | Oncology (specific type not disclosed) | Pre-clinical |
| INTRAMETICS Platform Candidates | Oncology (multiple cancers driven by IDPs) | Discovery/Pre-clinical |
Leadership Team at IDP Pharma
SE
Santiago Esteban
Co-founder & CEO
TH
Tim Hammond
Chief Development Officer
AS
Andrew Saunders
Medical Director
DM
David Molina
Clinical Operations Manager
LO
Laura Orozco
Head of Finance
TS
Tomi Sawyer
Scientific Advisory Board Chairman
DW
Dean W. Felsher
Scientific Advisory Board Member